Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-003138-26Phase 4Active
Phase 4, single-arm trial of influenza vaccine in myasthenia gravis (MG) and influenza, sponsored by Leiden University Medical Center. Primary endpoint: Change in influenza-specific serum IgG titer. Started Aug 2016; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-003138-26.